Quality of healing in peptic ulcer disease—are H2 receptor antagonists all we need?-Reference-Cited by-同舟云学术

Quality of healing in peptic ulcer disease—are H2 receptor antagonists all we need?

Published:1993-05 Issue:S5 Volume:28 Page:168-171
ISSN:0435-1339
Container-title:Gastroenterologia Japonica
language:en
Short-container-title:Gastroenterol Jpn

Author:

Korman Melvyn G.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF02989229.pdf

Reference24 articles.

1. Hansky J, Korman MG. Long term cimetidine in duodenal ulcer. Dig Dis Sci 1979;24: 465–467.

2. Bardham KD, Hinchcliffe RFC, Bose K, et al. Six years of continuous cimetidine treatment in peptic ulcer disease, “efficacy and safety”. Aliment Pharmacol Therap 1988;2: 394–405.

3. Penston JG, Wormsley KG. Efficacy and safety of long term maintenance therapy of duodenal ulcers. Scand J Gastroenterol 1989; 24: 1145–1152.

4. Pounder RE. Maintenance treatment: who should be treated and for how long? In: Maintenance treatment, a strategy for the management of peptic ulcer disease. Oxford: The Medicine Group (UK) Ltd, 1988;14–15.

5. Glise H, Martinsson J, Solhaug JH, et al. Two and four weeks treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scand J Gastroenterol 1991;26: 137–145.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of lansoprazole and omeprazole in the short-term management of duodenal ulcers in Taiwan;Journal of Gastroenterology and Hepatology;1995-10

2. Roxatidine versus ranitidine in the short-term management of duodenal ulcer: a randomized, double-blind trial;Current Therapeutic Research;1995-10